Doctors Rally in Support of Morcellator Use Curbed by FDA

Share this content:
Doctors Rally in Support of Morcellator Use Curbed by FDA
Doctors Rally in Support of Morcellator Use Curbed by FDA

WEDNESDAY, Dec. 9, 2015 (HealthDay News) -- Dozens of gynecologists, oncologists, and women's health experts are challenging a U.S. Food and Drug Administration warning on power morcellator use for the removal of uterine fibroids.

The professional group claims that curbing its use may force patients to undergo riskier, more invasive procedures.

The FDA issued a boxed warning label on the devices last year. The agency had concluded that in about one out of every 458 cases, the morcellator might inadvertently spread undiagnosed cancer cells within the peritoneal cavity. But a review group of 46 experts says the likelihood that power morcellation would spread a cancerous growth is actually much lower.

"The best case scenario would be for the FDA to recalculate the prevalence estimates to make them more accurate," William Parker, M.D., director of minimally invasive gynecologic surgery at University of California, Los Angeles, Medical Center in Santa Monica, told HealthDay. Parker is the lead author of a new paper published online Dec. 7 in Obstetrics & Gynecology that criticizes the FDA's action. The authors have also issued an open letter to the FDA asking it to change course.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »